Cargando…
Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization
Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097100/ https://www.ncbi.nlm.nih.gov/pubmed/37050412 http://dx.doi.org/10.3390/polym15071798 |
_version_ | 1785024498413600768 |
---|---|
author | Ullah, Irshad Farooq, Ayesha Shuja Naz, Iffat Ahmad, Waqar Ullah, Hidayat Sehar, Shama Nawaz, Asif |
author_facet | Ullah, Irshad Farooq, Ayesha Shuja Naz, Iffat Ahmad, Waqar Ullah, Hidayat Sehar, Shama Nawaz, Asif |
author_sort | Ullah, Irshad |
collection | PubMed |
description | Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels. |
format | Online Article Text |
id | pubmed-10097100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-100971002023-04-13 Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization Ullah, Irshad Farooq, Ayesha Shuja Naz, Iffat Ahmad, Waqar Ullah, Hidayat Sehar, Shama Nawaz, Asif Polymers (Basel) Article Hydrogel is one of the most interesting and excellent candidates for oral drug delivery. The current study focuses on formulation development of hydrogels for controlled oral delivery of esomeprazole. The hydrogels were prepared by solution casting method by dissolving polymers in Polyvinyl alcohol (PVA) solution. Calcium alginate, Hydroxyl propyl methylcellulose (HPMC), acrylic acid and chondroitin sulfate were used in the preparation of hydrogels. Fourier transform infrared (FTIR) analysis showed no incompatibilities between drug and excipients used in the preparation of formulations. The hydrogels were characterized for size and surface morphology. Drug encapsulation efficiency was measured by Ultraviolet-visible (UV-VIS) spectroscopy. In vitro release studies were carried out using dissolution apparatus. The formulated hydrogels were then compared with the marketed product in vivo using rabbits. The result indicates that prepared hydrogels have a uniform size with a porous surface. The esomeprazole encapsulation efficiency of the prepared hydrogels was found to be 83.1 ± 2.16%. The esomeprazole-loaded hydrogel formulations showed optimum and Pharmacopeial acceptable range swelling behavior. The release of esomeprazole is controlled for 24 h (85.43 ± 0.32% in 24 h). The swelling and release of drug results make the prepared hydrogels a potential candidate for the controlled delivery of esomeprazole. The release of the drug from prepared hydrogel followed the super case transport-2 mechanism. The in vivo studies showed that prepared hydrogel formulations showed controlled and prolonged release of esomeprazole as compared to drug solution and marketed product. The formulations were kept for stability studies; there was no significant change observed in physical parameters, i.e., (appearance, color change and grittiness) at 40 °C ± 2/75% ± RH. There was a negligible difference in the drug content observed after the stability study suggested that all the formulations are stable under the given conditions for 60 days. The current study provides a valuable perspective on the controlled release profile of Hydroxyl propyl methylcellulose (HPMC) and calcium alginate-based esomeprazole hydrogels. MDPI 2023-04-06 /pmc/articles/PMC10097100/ /pubmed/37050412 http://dx.doi.org/10.3390/polym15071798 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ullah, Irshad Farooq, Ayesha Shuja Naz, Iffat Ahmad, Waqar Ullah, Hidayat Sehar, Shama Nawaz, Asif Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title | Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title_full | Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title_fullStr | Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title_full_unstemmed | Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title_short | Fabrication of Polymeric Hydrogels Containing Esomeprazole for Oral Delivery: In Vitro and In Vivo Pharmacokinetic Characterization |
title_sort | fabrication of polymeric hydrogels containing esomeprazole for oral delivery: in vitro and in vivo pharmacokinetic characterization |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097100/ https://www.ncbi.nlm.nih.gov/pubmed/37050412 http://dx.doi.org/10.3390/polym15071798 |
work_keys_str_mv | AT ullahirshad fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT farooqayeshashuja fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT naziffat fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT ahmadwaqar fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT ullahhidayat fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT seharshama fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization AT nawazasif fabricationofpolymerichydrogelscontainingesomeprazolefororaldeliveryinvitroandinvivopharmacokineticcharacterization |